# Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

> **NCT01447732** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 71 (actual)

## Conditions studied

- Solid Tumour
- Adenocarcinoma of the Colorectal
- Adenocarcinoma of the Pancreas

## Interventions

- **DRUG:** CEP-37250/KHK2804

## Key facts

- **NCT ID:** NCT01447732
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2024-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447732, "Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01447732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*